Health and Fitness Health and Fitness

Mon, November 14, 2011

[ Mon, Nov 14th 2011 ] - Market Wire

Daxor Corporation Announces Third Quarter 2011 Earnings

[ Mon, Nov 14th 2011 ] - Market Wire

Amica Mature Lifestyles Announces First Quarter R .. sults for Fiscal 2012 and Second Quarter Dividend

[ Mon, Nov 14th 2011 ] - Market Wire

ImmuCell Announces Product Sales Growth and Other Financial Results for Third Quarter of 2011

[ Mon, Nov 14th 2011 ] - Market Wire

El ltimo instrumento de pruebas mvil comprueba el consumo de drogas en los conductores

[ Mon, Nov 14th 2011 ] - Market Wire

Adherex Reports Recent Developments and Third Quarter September 30, 2011 Financial Results

[ Mon, Nov 14th 2011 ] - Market Wire

Cadence Pharmaceuticals Announces Proposed Public Offering of Common Stock

[ Mon, Nov 14th 2011 ] - Market Wire

Horizon Pharma and Sanofi Announce FDA Approval of DUEXIS(R) Commercial Manufacturing Facility

[ Mon, Nov 14th 2011 ] - Market Wire

30 AM Eastern Time

[ Mon, Nov 14th 2011 ] - Market Wire

15-Minute Data From Phase 3 Study of Avanafil Fea .. a Late Breaking Abstract at SMSNA Annual Meeting

[ Mon, Nov 14th 2011 ] - Market Wire

Small Cap Conference in New York City on November .. nstitutional Investors, Top Brokers, High Net-Wor

[ Mon, Nov 14th 2011 ] - Market Wire

Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results

[ Mon, Nov 14th 2011 ] - Market Wire

OncoSec to Present at Medical Device Investor Forum

[ Mon, Nov 14th 2011 ] - Market Wire

L'ultimo dispositivo di verifica mobile prende di mira chi guida sotto l'effetto di droghe

[ Mon, Nov 14th 2011 ] - Market Wire

Neuestes mobiles Testgert nimmt Fahrer unter Drogeneinfluss ins Visier

[ Mon, Nov 14th 2011 ] - Market Wire

Latest Mobile Testing Device Targets Drug Drivers

Sun, November 13, 2011

[ Sun, Nov 13th 2011 ] - Market Wire

Pharmasset to Present at the Lazard Capital Markets Healthcare Conference

[ Sun, Nov 13th 2011 ] - Market Wire

Oncothyreon Presents Data from Phase 1/2 Trials o .. Docetaxel and with Cetuximab at 2011 AACR-NCI-EOR

[ Sun, Nov 13th 2011 ] - Market Wire

German Researchers Reaffirm Utility of Angiomax(R .. Angiox(R) (Bivalirudin) in High Risk PCI Patients

[ Sun, Nov 13th 2011 ] - Market Wire

American Medical Systems annonce le lancement europen de son rservoir compact Conceal

Sat, November 12, 2011

[ Sat, Nov 12th 2011 ] - Market Wire

Exelixisa Cabozantinib Phase 2 Data Demonstrate R .. cotic Analgesic Use in Patients with Previously T

[ Sat, Nov 12th 2011 ] - Market Wire

Preliminary Data Demonstrate that 40 mg Daily Dos .. Yields a High Rate of Bone Scan Response in mCRPC

[ Sat, Nov 12th 2011 ] - Market Wire

Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting

[ Sat, Nov 12th 2011 ] - Market Wire

AMAG Pharmaceuticals, Inc. Announces Positive Dat .. d-to-Head Comparison Trial of Ferumoxytol (Ferahe

Fri, November 11, 2011

[ Fri, Nov 11th 2011 ] - Market Wire

North Carolina Medicaid Issues Favorable Policy on ZOLL LifeVest Wearable Defibrillator

[ Fri, Nov 11th 2011 ] - Market Wire

Affymax and Takeda Report Additional Analyses of .. in Dialysis Patients at the American Society of N

[ Fri, Nov 11th 2011 ] - Market Wire

Hansen Medical Announces World's First Clinical U .. TM) Robotic System in Peripheral Vascular Disease

[ Fri, Nov 11th 2011 ] - Market Wire

National Campaign Shows Veterans Why "It's Worth the Fight" Against Advanced Prostate Cancer

[ Fri, Nov 11th 2011 ] - Market Wire

SDIX Agrees to Sell Water Quality Assets to Modern Water plc for $4.5 Million

[ Fri, Nov 11th 2011 ] - Market Wire

Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference

[ Fri, Nov 11th 2011 ] - Market Wire

GencaroTM Atrial Fibrillation and Pharmacogenetic .. erican Heart Association Scientific Sessions 2011

[ Fri, Nov 11th 2011 ] - Market Wire

MAKO Surgical and Hansen Medical Making Headway With Their Products

[ Fri, Nov 11th 2011 ] - Market Wire

Brainstorm's Clinical Trials Featured on the Israeli Radio Popular Morning News (Yoman Haboker)

[ Fri, Nov 11th 2011 ] - Market Wire

Orexigen Therapeutics to Present at the Lazard Capital Markets Healthcare Conference

[ Fri, Nov 11th 2011 ] - Market Wire

NxStage Awarded Multi-Year Contract to Supply Atl .. vices with Vasc-Alert Access Surveillance Solutio

[ Fri, Nov 11th 2011 ] - Market Wire

American Medical Systems kndigt europaweite Einfhrung des Flachbehlters Conceal an

[ Fri, Nov 11th 2011 ] - Market Wire

NeoStem Provides Updates, Reports Results for Thi .. arter and Upcoming November Company Presentations

[ Fri, Nov 11th 2011 ] - Market Wire

MedCath Corporation Schedules Release of Fourth Quarter Results

[ Fri, Nov 11th 2011 ] - Market Wire

Winner Medical to Participate in Upcoming Investor Conferences in China

Thu, November 10, 2011

[ Thu, Nov 10th 2011 ] - Market Wire

Hansen Medical's Magellan(TM) Robotic System to Be Presented at International Symposium

[ Thu, Nov 10th 2011 ] - Market Wire

Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System

[ Thu, Nov 10th 2011 ] - Market Wire

Merck Highlights Pipeline Progress and Showcases Novel Innovations at R&D and Business Briefing

[ Thu, Nov 10th 2011 ] - Market Wire

Critical Alerts for Merck, du Pont, Union Pacific .. s Pharmaceutical Released by Seven Summits Resear

[ Thu, Nov 10th 2011 ] - Market Wire

Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference

[ Thu, Nov 10th 2011 ] - Market Wire

Cytori to Webcast Presentation at the Lazard Capi .. Annual Healthcare Conference on November 16, 2011

[ Thu, Nov 10th 2011 ] - Market Wire

Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs

[ Thu, Nov 10th 2011 ] - Market Wire

Marina Biotech, Inc. Announces Third Quarter 2011 Financial Results

[ Thu, Nov 10th 2011 ] - Market Wire

Palatin Technologies, Inc. to Report Fiscal Year .. 9; Teleconference and Webcast to be held on N

[ Thu, Nov 10th 2011 ] - Market Wire

Uzbekistan's Airport Orders Implant Sciences' Qua .. iffer QS-H150 Handheld Explosives Trace Detectors

[ Thu, Nov 10th 2011 ] - Market Wire

Warnex in Negotiations to Extend Maturity Date of .. ing Debentures and to Obtain Additional Financing

[ Thu, Nov 10th 2011 ] - Market Wire

Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference

[ Thu, Nov 10th 2011 ] - Market Wire

BioDelivery Sciences Initiates Confirmatory Pharm .. BEMA Buprenorphine/Naloxone Compared to Suboxone

[ Thu, Nov 10th 2011 ] - Market Wire

Aduro BioTech Patent Upheld by USPTO

[ Thu, Nov 10th 2011 ] - Market Wire

HeartWare to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

Wed, November 9, 2011

[ Wed, Nov 09th 2011 ] - Market Wire

NuVasive to Participate in the Lazard Health Care Conference

[ Wed, Nov 09th 2011 ] - Market Wire

Scripps Health and The Medicines Company Announce .. te Breaking BRIDGE Trial Results Presented at TCT

[ Wed, Nov 09th 2011 ] - Market Wire

ProMetic to Hold Third Quarter 2011 Financial Results Conference Call and Webcast

[ Wed, Nov 09th 2011 ] - Market Wire

CE Mark for Verisante Aura(TM) Opens Doors to Massive European Market

[ Wed, Nov 09th 2011 ] - Market Wire

BIOLASE to Present at Lazard Capital Markets Healthcare Conference

[ Wed, Nov 09th 2011 ] - Market Wire

ISS Proxy Advisory Services Recommends Poniard Sh .. 's Proposed Merger With ALLOZYNE and Reverse Stoc

[ Wed, Nov 09th 2011 ] - Market Wire

Unigene Announces Positive Top-Line Results of Ph .. Treatment of Osteoporosis in Postmenopausal Women

[ Wed, Nov 09th 2011 ] - Market Wire

ProPhase Labs Reports Third Quarter 2011 Results

[ Wed, Nov 09th 2011 ] - Market Wire

Mylan to Acquire Pfizer Respiratory Delivery Platform

[ Wed, Nov 09th 2011 ] - Market Wire

GenVec Reports Third Quarter 2011 Financial Results

[ Wed, Nov 09th 2011 ] - Market Wire

LCA-Vision to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

[ Wed, Nov 09th 2011 ] - Market Wire

Uroplasty Announces Issuance of New Apparatus Pat .. r the Urgent PC Neuromodulation System Stimulator

[ Wed, Nov 09th 2011 ] - Market Wire

JCM Passes Internal Quality Assessment for Azithromycin API Production

[ Wed, Nov 09th 2011 ] - Market Wire

LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference

[ Wed, Nov 09th 2011 ] - Market Wire

Dako Enters New Collaboration With Bristol-Myers Squibb on Pharmacodiagnostics

Tue, November 8, 2011

[ Tue, Nov 08th 2011 ] - Market Wire

Allon Therapeutics Releases Q3 Operating Results and Provides Corporate Update

[ Tue, Nov 08th 2011 ] - Market Wire

Boston Scientific Platinum Chromium IONa" Stent D .. tes Positive Outcomes in PERSEUS Clinical Program

[ Tue, Nov 08th 2011 ] - Market Wire

Daxor Corporation Announces Payment of a Fourth Quarter Dividend

[ Tue, Nov 08th 2011 ] - Market Wire

Acquisition Spotlight Shines on Hepatitis C Drug Developers

[ Tue, Nov 08th 2011 ] - Market Wire

Discovery Labs Releases New AFECTAIRa" Performanc .. can Association for Respiratory Care Annual Meeti

[ Tue, Nov 08th 2011 ] - Market Wire

Psychemedics erhlt internationale ISO/IEC 17025-Akkreditierung

[ Tue, Nov 08th 2011 ] - Market Wire

PROLOR Biotech to Present at Lazard Capital Markets 8th Annual Healthcare Conference

[ Tue, Nov 08th 2011 ] - Market Wire

BioSpecifics Technologies Corp. Reports Third Quarter 2011 Financial Results

[ Tue, Nov 08th 2011 ] - Market Wire

CONMED Corporation to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

[ Tue, Nov 08th 2011 ] - Market Wire

Given Imaging to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

[ Tue, Nov 08th 2011 ] - Market Wire

Uroplasty to Present at Two Upcoming Conferences

[ Tue, Nov 08th 2011 ] - Market Wire

Omeros Corporation Reports Third Quarter 2011 Financial Results

[ Tue, Nov 08th 2011 ] - Market Wire

PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference

[ Tue, Nov 08th 2011 ] - Market Wire

Lilly and Amylin Mutually Agree to End Diabetes A .. and Transition Exenatide Responsibility to Amylin

[ Tue, Nov 08th 2011 ] - Market Wire

Abbott Reports Five-Year Data for HUMIRA (Adalimumab) in Ankylosing Spondylitis

Mon, November 7, 2011

[ Mon, Nov 07th 2011 ] - Market Wire

Cantel Medical Corp. to Present at the Stephens Inc. Fall Investment Conference

[ Mon, Nov 07th 2011 ] - Market Wire

Medivation, American International Group, Tech Data, Apple and Google

[ Mon, Nov 07th 2011 ] - Market Wire

Critical Stock Alerts for Johnson & Johnson, RF M .. rox, Wells Fargo, Health Care REIT & UnitedHealth

[ Mon, Nov 07th 2011 ] - Market Wire

Southwest Healthcare System Regulatory Update

[ Mon, Nov 07th 2011 ] - Market Wire

Neogen Develops Quicker Test for Yeast and Mold

[ Mon, Nov 07th 2011 ] - Market Wire

Comprehensive Care Corporation Names Robert R. Kulbick New President

[ Mon, Nov 07th 2011 ] - Market Wire

Glass Lewis Recommends Poniard Shareholders Vote .. osed Merger With ALLOZYNE and Reverse Stock Split

[ Mon, Nov 07th 2011 ] - Market Wire

[ Mon, Nov 07th 2011 ] - Market Wire

Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011

[ Mon, Nov 07th 2011 ] - Market Wire

Top 5 Global Pharmaceutical Company Selects NewCardio's QTinno for Phase I Drug Safety Trial

[ Mon, Nov 07th 2011 ] - Market Wire

Implant Sciences Announces New Sales in Japan and .. uclear Power Plant Protection and Law Enforcement

[ Mon, Nov 07th 2011 ] - Market Wire

Syneron's New ePrimea" Device Featured on The Doctors Show as the Latest Super Age Eraser

[ Mon, Nov 07th 2011 ] - Market Wire

PAREXEL International to Present at Lazard Capita .. care Conference and Citi Small/Mid Cap Conference

[ Mon, Nov 07th 2011 ] - Market Wire

Abbott Presents HUMIRA (Adalimumab) Phase 3 Study .. h Active Non-Radiographic Axial Spondyloarthritis

Sun, November 6, 2011

[ Sun, Nov 06th 2011 ] - Market Wire

Galapagos to present results for selective JAK1 i .. rheumatoid arthritis patients on 22 November 2011

[ Sun, Nov 06th 2011 ] - Market Wire

Helix BioPharma Corp. Announces Meeting of Shareholders

[ Sun, Nov 06th 2011 ] - Market Wire

Abbott Announces New Long-Term Data Evaluating Us .. Patients with Long-Standing Moderate to Severe Rh

[ Sun, Nov 06th 2011 ] - Market Wire

Daten des ersten Teils einer Phase-2-Studie unter .. fr die hufigste Form von Mukoviszidose (F508del),

Sat, November 5, 2011

[ Sat, Nov 05th 2011 ] - Market Wire

Prolia (denosumab) Open-Label Extension Trial Sho .. e Mineral Density Over Six Years With Similar Saf

[ Sat, Nov 05th 2011 ] - Market Wire

Treatment With Enbrel (etanercept) Shows Signific .. nefits in Rheumatoid Arthritis (RA) Patients With

[ Sat, Nov 05th 2011 ] - Market Wire

Savient Pharmaceuticals Announces New Data Surrou .. t of Refractory Chronic Gout at the American Coll

[ Sat, Nov 05th 2011 ] - Market Wire

Teleflex to Focus on Innovative Products and Solu .. American Association of Respiratory Care Congress

[ Sat, Nov 05th 2011 ] - Market Wire

Kinetic Concepts, Inc. Completes Merger with Apax Consortium

[ Sat, Nov 05th 2011 ] - Market Wire

CareFusion Announces New Ventilation Solution to .. ls Provide Improved Patient Care and Reduce Costs

[ Sat, Nov 05th 2011 ] - Market Wire

Health Net Wins Two Awards in 2011 National Health Information Awards Program

[ Sat, Nov 05th 2011 ] - Market Wire

BioMimetic Therapeutics, Inc. to Report 2011 Third Quarter Financial Results on November 8

[ Sat, Nov 05th 2011 ] - Market Wire

Interim Data for Merck's VICTRELISTM (boceprevir) .. ents with Chronic Hepatitis C Genotype 1 to be Pr

[ Sat, Nov 05th 2011 ] - Market Wire

Gilead Announces Positive Five-Year Data Showing .. rosis and Cirrhosis Caused by Chronic Hepatitis B

[ Sat, Nov 05th 2011 ] - Market Wire

Interim Data for Merck';;s VICTREL .. ll Responder Patients with Chronic Hepatitis C Ge

[ Sat, Nov 05th 2011 ] - Market Wire

Interim Data for Merck';;;s VIC .. or Null Responder Patients with Chronic Hepatitis

[ Sat, Nov 05th 2011 ] - Market Wire

Medtronicas Unmatched Portfolio of Cardiovascular .. ices Features Prominently on Program for TCT 2011

[ Sat, Nov 05th 2011 ] - Market Wire

Bull & Lifshitz, LLP Announces Investigation of Adolor Corporation

Fri, November 4, 2011

[ Fri, Nov 04th 2011 ] - Market Wire

iBio, Inc. Receives Notice from NYSE Amex Staff t .. ntly is Below Certain Continued Listing Standards

[ Fri, Nov 04th 2011 ] - Market Wire

CML HealthCare Inc. Announces Release Date for 2011 Third Quarter Financial Results

[ Fri, Nov 04th 2011 ] - Market Wire

URBAN AG Names Billy V. Ray Jr. President and Member of Board of Directors

[ Fri, Nov 04th 2011 ] - Market Wire

CML HealthCare Inc. Celebrates Medical Radiation Technologists Week-November 6-12, 2011

[ Fri, Nov 04th 2011 ] - Market Wire

KCI e consrcio dirigidos pela Apax Partners anunciam concluso das conversaes sobre gesto executiva

[ Fri, Nov 04th 2011 ] - Market Wire

Acorda Therapeutics Reports Third Quarter 2011 Financial Results

[ Fri, Nov 04th 2011 ] - Market Wire

Ardea Biosciences Reports Recent Accomplishments, .. g Events and Third Quarter 2011 Financial Results

[ Fri, Nov 04th 2011 ] - Market Wire

Cancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative as Hoped

[ Fri, Nov 04th 2011 ] - Market Wire

Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected

[ Fri, Nov 04th 2011 ] - Market Wire

Equity Research on Raptor Pharmaceuticals Corp. a .. Mixed Results for Diagnostic Substances Industry

[ Fri, Nov 04th 2011 ] - Market Wire

For The Earth Corporation Grows Globally

[ Fri, Nov 04th 2011 ] - Market Wire

Novadaq Reports Third Quarter 2011 Financial Results

[ Fri, Nov 04th 2011 ] - Market Wire

Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility

[ Fri, Nov 04th 2011 ] - Market Wire

Quest Diagnostics anuncia el lanzamiento del test .. Direct para gripe y virus respiratorios en Europa

Thu, November 3, 2011

[ Thu, Nov 03rd 2011 ] - Market Wire

Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China

[ Thu, Nov 03rd 2011 ] - Market Wire

Humana Inc. to Present at the Credit Suisse 2011 Healthcare Conference

[ Thu, Nov 03rd 2011 ] - Market Wire

Sirona Biochem Announces New Grant of Stock Options

[ Thu, Nov 03rd 2011 ] - Market Wire

MSA Declares Fourth Quarter Dividend

[ Thu, Nov 03rd 2011 ] - Market Wire

Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results

[ Thu, Nov 03rd 2011 ] - Market Wire

SpectraScience to Hold Business Update Conference Call on November 10, 2011

[ Thu, Nov 03rd 2011 ] - Market Wire

BioElectronics' Study on Postoperative Pain Reduc .. ublished in the Aesthetic Plastic Surgery Journal

[ Thu, Nov 03rd 2011 ] - Market Wire

MethylGene Reports Third Quarter 2011 Financial Results and Provides Clinical Update

[ Thu, Nov 03rd 2011 ] - Market Wire

Dynavax Prices Public Offering of Common Stock

[ Thu, Nov 03rd 2011 ] - Market Wire

SecureAlert, Inc. and Commonwealth of Puerto Rico .. Violence With Focus on Family Safety and Real-Tim

[ Thu, Nov 03rd 2011 ] - Market Wire

Celsion Corporation to Hold Third Quarter 2011 Fi .. ts Conference Call on Thursday, November 10, 2011

[ Thu, Nov 03rd 2011 ] - Market Wire

FONAR Reports Error in Reports Regarding Its Common Stock

[ Thu, Nov 03rd 2011 ] - Market Wire

Medivation and Astellas Announce Positive Surviva .. of Phase 3 AFFIRM Trial of MDV3100 in Men With Ad

[ Thu, Nov 03rd 2011 ] - Market Wire

Kraig Biocraft Laboratories, Inc. Signs Spider Si .. cense Agreement With the University of Notre Dame

Wed, November 2, 2011

[ Wed, Nov 02nd 2011 ] - Market Wire

ING 3Q11 underlying net profit increases to EUR 1,285 million

[ Wed, Nov 02nd 2011 ] - Market Wire

Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results

[ Wed, Nov 02nd 2011 ] - Market Wire

Dynavax Announces Proposed Public Offering of Common Stock

[ Wed, Nov 02nd 2011 ] - Market Wire

Stellar Biotechnologies to Submit Documents for Registration of Shares in the U.S.

[ Wed, Nov 02nd 2011 ] - Market Wire

BIOLASE to Present at WJB Capital Group's Laser Company -- Management Access Event

[ Wed, Nov 02nd 2011 ] - Market Wire

NuPathe Appoints Bart J. Dunn as Vice President, Corporate Development &;; Licensing

[ Wed, Nov 02nd 2011 ] - Market Wire

ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th

[ Wed, Nov 02nd 2011 ] - Market Wire

Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation

[ Wed, Nov 02nd 2011 ] - Market Wire

Faster FDA Review Process Bodes Well for NPS Pharmaceuticals and Cel-Sci Corp

[ Wed, Nov 02nd 2011 ] - Market Wire

IBEX Reports Q4 and Fiscal 2011 Results

[ Wed, Nov 02nd 2011 ] - Market Wire

New Studies Show GERD Is Best Assessed Off PPI Therapy

[ Wed, Nov 02nd 2011 ] - Market Wire

MELA Sciences Announces FDA Approval for MelaFind(R)

[ Wed, Nov 02nd 2011 ] - Market Wire

Medivation Announces Third Quarter Financial Resu .. ts Teleconference and Webcast on November 9, 2011

[ Wed, Nov 02nd 2011 ] - Market Wire

Threshold Pharmaceuticals Appoints Nipun Davar as .. t of Pharmaceutical Development and Manufacturing

Tue, November 1, 2011

[ Tue, Nov 01st 2011 ] - Market Wire

Solta and Medicis Announce Close of Agreement for LIPOSONIX

[ Tue, Nov 01st 2011 ] - Market Wire

ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results

[ Tue, Nov 01st 2011 ] - Market Wire

Critical Outcome Technologies Inc. to Deliver Pod .. on on COTI-2 at Influential Scientific Conference

[ Tue, Nov 01st 2011 ] - Market Wire

Syneron Sets New Facial Rejuvenation Standard Wit .. t the American Society of Dermatologic Surgery Co

[ Tue, Nov 01st 2011 ] - Market Wire

Immunovaccine to Report Q3 2011 Financial Results and Conference Call

[ Tue, Nov 01st 2011 ] - Market Wire

Equity Research on Pharmaceutical Product Develop .. cs Inc. - Acquisitions and Privatizations Dominat

[ Tue, Nov 01st 2011 ] - Market Wire

Aeolus Pharmaceuticals Announces Positive Results .. Neupogen(R) as Combination Therapy for Treatment

[ Tue, Nov 01st 2011 ] - Market Wire

Cytokinetics Announces Initiation of Second Cohor .. l Trial Evaluating CK-2017357 in Patients With AL

[ Tue, Nov 01st 2011 ] - Market Wire

VentriPoint Commences Clinical Studies of Pulmona .. ension Application of Right Heart Analysis System

[ Tue, Nov 01st 2011 ] - Market Wire

Imaging3, Inc. FDA 510(k) Protocol Meeting Update

[ Tue, Nov 01st 2011 ] - Market Wire

SciClone Pharmaceuticals to Report Third Quarter 2011 Financial Results on November 8

[ Tue, Nov 01st 2011 ] - Market Wire

Implant Sciences' Explosives Trace Detector Deployed at Middle East Embassy

[ Tue, Nov 01st 2011 ] - Market Wire

Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position

[ Tue, Nov 01st 2011 ] - Market Wire

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

Mon, October 31, 2011

[ Mon, Oct 31st 2011 ] - Market Wire

Santarus Announces Presentation of Pooled Data fr .. linical Studies at the ACG Annual Scientific Meet

[ Mon, Oct 31st 2011 ] - Market Wire

Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey

[ Mon, Oct 31st 2011 ] - Market Wire

Exelixis to Initiate Cabozantinib a306 Trial with Pain Endpoint in mCRPC

[ Mon, Oct 31st 2011 ] - Market Wire

SRI/Surgical Express Third Quarter 2011 Conference Call

[ Mon, Oct 31st 2011 ] - Market Wire

NPS Pharmaceuticals to Host Conference Call to Di .. can College of Gastroenterology Annual Scientific

[ Mon, Oct 31st 2011 ] - Market Wire

Medtronic Receives First FDA Approval of Cobalt C .. Expandable Stent to Treat Narrowed Iliac Arteries

[ Mon, Oct 31st 2011 ] - Market Wire

PharmStar to Pursue SEC Fully-Reporting Status

[ Mon, Oct 31st 2011 ] - Market Wire

Teva Presents New Data on QNASLa" at the 2011 Ame .. of Allergy, Asthma and Immunology Annual Meeting

[ Mon, Oct 31st 2011 ] - Market Wire

CytRx Announces Favorable Initial Results from it .. nical Trial in Patients with Soft Tissue Sarcomas

[ Mon, Oct 31st 2011 ] - Market Wire

Health Net Named to USO-Metroas Circle of Stars

[ Mon, Oct 31st 2011 ] - Market Wire

Trimel Initiates Dosing in Phase III Trial of CompleoTRT in Male Hypogonadal Patients

[ Mon, Oct 31st 2011 ] - Market Wire

Teleflex Launches New Website for Teleflex ISIS HVTa", the First Comprehensive Endotracheal Tube

[ Mon, Oct 31st 2011 ] - Market Wire

Illumina Names Dr. Daniel S. Grosu Chief Medical Officer

[ Mon, Oct 31st 2011 ] - Market Wire

Winner Medical Ranked High by CNTAC

Sat, October 29, 2011

[ Sat, Oct 29th 2011 ] - Market Wire

Gilead presenta solicitud de nuevo frmaco a la FD .. "Quad" de nica pastilla una vez al da para el VIH

Fri, October 28, 2011

[ Fri, Oct 28th 2011 ] - Market Wire

Almost Family, Inc. to Report Third Quarter 2011 Financial Results on November 2, 2011

[ Fri, Oct 28th 2011 ] - Market Wire

Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX

[ Fri, Oct 28th 2011 ] - Market Wire

The Ensign Group Schedules Third Quarter 2011 Earnings Call for Thursday, November 3, 2011

[ Fri, Oct 28th 2011 ] - Market Wire

Watson to Present at the 2011 Annual Credit Suisse Health Care Conference

[ Fri, Oct 28th 2011 ] - Market Wire

Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds

[ Fri, Oct 28th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company

[ Fri, Oct 28th 2011 ] - Market Wire

Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results

[ Fri, Oct 28th 2011 ] - Market Wire

Ergoresearch Ltd Reports Growing Sales of 9.0% fo .. 30, 2011. Earnings Before Tax for the Period Amou

[ Fri, Oct 28th 2011 ] - Market Wire

ZIOPHARM Presents Promising Preclinical Pediatric .. nd IV Palifosfamide at the 2011 CTOS/MSTS Meeting

[ Fri, Oct 28th 2011 ] - Market Wire

Medtronic Receives IDE Approval to Conduct ASPIRE .. sulin Pump with Low Glucose Suspend for US Market

[ Fri, Oct 28th 2011 ] - Market Wire

A Biogen Idec pozitv eredmnyt rt el a sclerosis m .. BG-12 (Dimethyl Fumarate) harmadik fzis klinikai

[ Fri, Oct 28th 2011 ] - Market Wire

MannKind Corporation to Hold 2011 Third Quarter F .. ncial Results Conference Call on November 3, 2011

[ Fri, Oct 28th 2011 ] - Market Wire

Advaxis Receives Additional Financing

[ Fri, Oct 28th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. Mylan Inc. and Medicis Pharmaceutical Corporation

PROLOR Biotech to Present at Lazard Capital Markets 8th Annual Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. al-markets-8th-annual-healthcare-conference.html}
^{Published in Health and Fitness on Tuesday, November 8th 2011 at 4:47 GMT by Market Wire}

PROLOR Biotech to Present at Lazard Capital Markets 8th Annual Healthcare Conference -- NES-ZIONA, Israel, Nov. 8, 2011 /PRNewswire/ --

PROLOR Biotech to Present at Lazard Capital Markets 8th Annual Healthcare Conference

[ ]

NES-ZIONA, Israel, Nov. 8, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: [ PBTH ]), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will give a corporate presentation at the Lazard Capital Markets 8th Annual Healthcare Conference at 9:00 AM EST on November 15, 2011. The conference will be held at the Pierre Hotel in New York City.

For more information about the Lazard 8th Annual Healthcare Conference, visit [ www.lazardcap.com/conferenceList.aspx?tn=4&ln=3&itm=3579&lid=1901 ]

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins. PROLOR is currently developing a long-acting version of human growth hormone, which has successfully completed a Phase II clinical trial. It also is developing long-acting versions of Factor VIIa and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist peptide for diabetes and obesity, as well as agents for atherosclerosis and rheumatoid arthritis, which are all in preclinical development. For more information, visit [ www.prolor-biotech.com ].

PROLOR CONTACT:	MEDIA CONTACT:
Shai Novik, President	Barbara Lindheim
PROLOR Biotech, Inc.	GendeLLindheim BioCom Partners
Tel: +1 866 644-7811	+1 212 584-2276
Email: [ shai@prolor-biotech.com ]	[ blindheim@biocompartners.com ]

SOURCE PROLOR Biotech, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.prolor-biotech.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire